The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
VAXELIS DTPa5-HB-IPV-Hib vaccine suspension for injection in 0.5 mL pre-filled syringe, Maxx Pharma Pty Ltd, CON-1270
Product name
VAXELIS DTPa5-HB-IPV-Hib vaccine suspension for injection in 0.5 mL pre-filled syringe
Sponsor name
Maxx Pharma Pty Ltd
ARTG
Batches
C24001 & C24007
Consent start
Consent no.
CON-1270
Duration
The consent is effective from 3 September 2024 until 3 September 2026.
Standard
subparagraph 8(1)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The syringe labels included in the product do not include the correct
distributor name that has been approved by the TGA.
Conditions imposed
Therapeutic product type
Prescription medicines